Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06385236 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping

Study acronym: EPIPHANY
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study description expanded, about 19 wordsv3 See this version in full on ClinicalTrials.gov ↗
  2. Re-verified, no change to tracked fieldsv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In this study, a new method will be used to evaluate response to 2 approved biologic therapies, and assess how well each patient responds to each asthma treatment. This study will measure the response to these treatments using genomic and biologic measurements obtained from participants biosamples. By evaluating response to 2 different biologic therapies, this study has the potential to provide an in-depth understanding of the mechanisms underlying severe asthma that will inform and change treatment decisions, and may ultimately lead to a change in the way that asthma patients are evaluated for potential personalized therapies and maximize the probability that the subject will respond to treatment.
Trial Details
NCT Number NCT06385236
Lead Sponsor University of California, San Diego
Collaborators: Mayo Clinic, Yale University, University of Arizona, Harvard University, Brigham and Women's Hospital, National Heart, Lung, and Blood Institute (NHLBI)
Conditions Moderate to Severe Asthma
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov